Anavex Life Sciences Corp (AVXL)

[tradeherpete]

The article in Nature pointed at this as well. Nice find TTT

Annual Scientific Meeting: Alzheimer’s Trials: Beyond Amyloid on October 11th in Sydney, Australia.

It’s good to be mentioned in a respected publication as Nature.

Nature also does a great recap of AD while giving a comprehensive overview of treatments. The pie chart shows 22% of trials still in amyloid theory while 17% in the Mitochondrial Cascade and related hypothesis.

Finally, to summarize this review of the history and progress of hypotheses and clinical trials for AD, the most perplexing question is in regards to amyloid hypothesis and its failed clinical trials, which account for 22.3% of all clinical trials

Anavex being mentioned towards the end of the piece, very favorably, says to me they are looking very hopefully for the Sigma 1 to be the next focus for Alzheimer’s.

Couldn't be better news for weary investors.

imo